Jo J - Search Results

1

Significance of CA72.4 in patients with colorectal cancer. Comparison with CEA and CA19.9.

Filella X, Molina R, Mengual PJ, Jo J, Ballesta AM. Filella X, et al. Among authors: jo j. J Nucl Biol Med (1991). 1991 Jul-Sep;35(3):158-61. J Nucl Biol Med (1991). 1991. PMID: 1816871

2

A prospective study of tumor markers CA 125 and CA 19.9 in patients with epithelial ovarian carcinomas.

Molina R, Ojeda B, Filella X, Borras G, Jo J, Mas E, Lopez JJ, Ballesta A. Molina R, et al. Among authors: jo j. Tumour Biol. 1992;13(5-6):278-86. doi: 10.1159/000217776. Tumour Biol. 1992. PMID: 1290025

3

Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant disease.

Filella X, Molina R, Jo J, Bedini JL, Joseph J, Ballesta AM. Filella X, et al. Among authors: jo j. Bull Cancer. 1992;79(3):271-7. Bull Cancer. 1992. PMID: 1392166 Review.

4

Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.

Filella X, Molina R, Jo J, Umbert B, Bedini JL, Ballesta AM. Filella X, et al. Among authors: jo j. Tumour Biol. 1990;11(6):289-94. doi: 10.1159/000217664. Tumour Biol. 1990. PMID: 1700860

5

Tumor markers in patients with chronic renal failure.

Filella X, Cases A, Molina R, Jo J, Bedini JL, Revert L, Ballesta AM. Filella X, et al. Among authors: jo j. Int J Biol Markers. 1990 Apr-Jun;5(2):85-8. Int J Biol Markers. 1990. PMID: 1704405

6

Serum phosphohexose isomerase activities in patients with colorectal cancer.

Filella X, Molina R, Jo J, Mas E, Ballesta AM. Filella X, et al. Among authors: jo j. Tumour Biol. 1991;12(6):360-7. doi: 10.1159/000217737. Tumour Biol. 1991. PMID: 1798910

7

Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases.

Molina R, Filella X, Bruix J, Mengual P, Bosch J, Calvet X, Jo J, Ballesta AM. Molina R, et al. Among authors: jo j. Clin Chem. 1991 Aug;37(8):1379-83. Clin Chem. 1991. PMID: 1868598

8

Clinical usefulness of CEA as tumor marker in patients with colorectal cancer.

Filella X, Molina R, Bedini JL, Jo J, Joseph J, Ballesta AM. Filella X, et al. Among authors: jo j. J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):107-10. J Nucl Med Allied Sci. 1990. PMID: 2092102 No abstract available.

9

Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients.

Molina R, Zanón G, Filella X, Moreno F, Jo J, Daniels M, Latre ML, Giménez N, Pahisa J, Velasco M, et al. Molina R, et al. Among authors: jo j. Breast Cancer Res Treat. 1995;36(1):41-8. doi: 10.1007/BF00690183. Breast Cancer Res Treat. 1995. PMID: 7579505 Clinical Trial.

10

Carcinoembryonic antigen in staging and follow-up of patients with solid tumors.

Ballesta AM, Molina R, Filella X, Jo J, Giménez N. Ballesta AM, et al. Among authors: jo j. Tumour Biol. 1995;16(1):32-41. doi: 10.1159/000217926. Tumour Biol. 1995. PMID: 7863220 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,050 results

Search Page

Filters